9-(2,3-Di-O-acetyl-6-O-benzoyl-5-deoxy-D-ribo-exofuranoyl)-6-chloropurine
CAT:
804-HY-154669
Size:
Inquire
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

9-(2,3-Di-O-acetyl-6-O-benzoyl-5-deoxy-D-ribo-exofuranoyl)-6-chloropurine
- UNSPSC Description: 9-(2,3-Di-O-acetyl-6-O-benzoyl-5-deoxy-D-ribo-exofuranoyl)-6-chloropurine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
- Target Antigen: Nucleoside Antimetabolite/Analog
- Type: Oligonucleotides
- Related Pathways: Cell Cycle/DNA Damage
- Applications: Cancer-programmed cell death
- Field of Research: Cancer
- Assay Protocol: https://www.medchemexpress.com/9-2-3-di-o-acetyl-6-o-benzoyl-5-deoxy-d-ribo-exofuranoyl-6-chloropurine.html
- Solubility: 10 mM in DMSO
- Smiles: O=C(O[C@H]1[C@@H](OC(C)=O)[C@H](N(C=N2)C3=C2C(Cl)=NC=N3)O[C@@H]1CCOC(C4=CC=CC=C4)=O)C
- Molecular Weight: 488.88
- References & Citations: [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported